For Her Heart's Sake STEP Project: A Clinical Trial (FHHS: STEP)

October 31, 2016 updated by: University of Manitoba

For Her Heart's Sake: A Clinical Trial to Assess Strategies to Enhance Participation in Cardiac Rehabilitation - STEP Project

The goal of the proposed project is to determine if providing an intervention for women who decline the invitation to participate in standard cardiac rehabilitation programs (CRPs) will ultimately result in an increase their participation in CRPs.This study will evaluate outcomes of patients randomized to the FHHS STEP Program versus by non-STEP Program participants. The overall goal is to provide an alternate, introductory program that will engage, educate, and empower women following a cardiac event. Providing these women with the necessary personal resources will encourage and enable these women to take the step towards a cardiac rehabilitation program, which, in turn will ideally lead to a life-long commitment to heart health.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

Cardiac rehabilitation programs (CRPs) have been shown to improve outcomes following a cardiac event. Referrals to the CRP are a standard part of the community-based continuing care process within the Winnipeg region, to include automatic referrals for hospitalized patients, based on specific criteria, physician referrals and self-referrals. However, fewer women than men are referred to and participate in CRPs in Winnipeg.

The investigators' study is unique in that the investigators plan to capture those women who may not be ready to change or participate in a traditional CRP. While women who are in the pre-contemplative or contemplative stages of change may not be ready to participate in a standard CRP, they may be willing to explore a complementary opportunity: the FHHS STEP Program. The overall goal of this project is to provide a collaborative team environment that will engage women; educate, and empower women; and provide women with the necessary personal resources to enable them to take the step towards a cardiac rehabilitation program and a life-long commitment to heart health. The investigators' 2-group randomized clinical trial will compare physiological and psychosocial outcomes among women completing a 12-week gender specific introduction to cardiac rehabilitation with non-program attenders.

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Discharged from a Winnipeg Regional Health Authority (WRHA) facility;
  • Diagnosis of stable ischemic heart disease or acute coronary syndrome who have undergone revascularization via coronary artery bypass graft (CABG) surgery or elective percutaneous coronary intervention (PCI);
  • Diagnosis of valvular heart disease who have undergone valve surgery;
  • Diagnosis of stable ischemic or non-ischemic heart failure;
  • Able to read, write, and speak English;
  • Referred to and declined participation in a CRP in Winnipeg;
  • Willing and able to attend the STEP Program at the Victoria General Hospital.

Exclusion Criteria:

  • Patients who have unstable or recent unstable cardiac syndrome, as defined by:

    • Severe heart failure (New York Heart Association Class IV) or angina (Canadian Cardiovascular Society Class IV) symptoms
    • Non-re-vascularized > triple vessel disease
  • Non-repaired severe valvular heart disease (aortic or mitral area < 1.0cm2 or mean gradient > 40 mmhg or > 10mmHg [millimetres of mercury] respectively)
  • Severe systolic heart failure (LVEF [left ventricular ejection fraction] < 30%)
  • High risk stress test
  • Exercise induced ventricular arrhythmias or recent (within the past 6 months) hospitalization for ventricular arrhythmias
  • Unstable arrhythmias (i.e., bradycardia; tachyarrhythmias)
  • Previous attendance in a CRP
  • Physical limitations that would preclude ability to walk
  • Cognitive impairment/deficits that would preclude participation in the STEP Project
  • Automatic internal cardiac defibrillator in situ
  • On waitlist for cardiac procedure (e.g., cardiac surgery; PCI)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: STEP Program Group
Arm: Intervention: The 12-week STEP Program intervention will include: initial individual consult/goal setting; weekly 90 minute information/interactive sessions; individualized patient centred care; journaling
Intervention: The 12-week STEP Program will include: initial individual consult/goal setting; weekly 90 minute information/interactive sessions; individualized patient centred care; journaling
No Intervention: Usual Care Group
The usual care group will follow the routine model of care for post-discharge patients who do not participate in a CRP. Usual care group participants will be given the opportunity/option to participate in the STEP Program in 6 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiac Rehabilitation Program Enrolment
Time Frame: 12 months
3 yes/no questions: have you contacted a CRP; have you joined a CRP; do you plan to contact a CRP. if not, why not
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short-Form-36
Time Frame: baseline, 3, 6 and 12 months
36 items re 8 dimensions: physical functioning (10 items), role limitations - physical (4 items), bodily pain (2 items), social functioning (2 items), general mental health (5 items), role limitations - emotional (3 items), vitality (4 items), general health perceptions, 5 items); coded to 0-100 score, with higher values representing more favourable states
baseline, 3, 6 and 12 months
Brief Symptom Inventory
Time Frame: baseline, 3, 6 and 12 months
53 items; 5-point Likert scale (1-5); operationalizes concepts of anxiety, depression and hostility; 9 symptom domains, with higher scores indicating greater levels of distress.
baseline, 3, 6 and 12 months
General Self-Efficacy Scale
Time Frame: baseline, 3, 6, 12 months
10 items; scoring based on 4-point Likert scale (1-4), with higher scores reflecting higher perceived self-efficacy
baseline, 3, 6, 12 months
Multidimensional Self-Efficacy for Exercise Scale
Time Frame: baseline, 3, 6 and 12 months
9 items; 11-point Likert scale (0-10), with higher scores reflecting higher task efficacy (3 items), coping efficacy (3 items) and scheduling efficacy (3 items
baseline, 3, 6 and 12 months
Enhancing Recovery in Coronary Heart Disease Social Support Instrument
Time Frame: baseline, 3, 6 and 12 months
7 item scale is scored by totalling the six 5-point Likert scale items and a 7th item, which is scored 4 for 'yes' and 2 for 'no'. The scale captures structural, emotional and instrumental support
baseline, 3, 6 and 12 months
Stages of Change Questionnaire
Time Frame: baseline, 3, 6 and 12 months
12 5-point-Likert scale (1-5) questions; Stages of readiness to change for each of the listed behaviors include 5 response items representing each of the stages of change (i.e., precontemplation, contemplation, preparation, action, and maintenance).
baseline, 3, 6 and 12 months
Health Resource Utilization Questionnaire
Time Frame: 3, 6 and 12 months
4-items: self-reported number of contacts/visits with primary care provider, cardiologist, emergency department/Walk-in Clinic visits and hospital admissions.
3, 6 and 12 months
International Physical Activity Questionnaire
Time Frame: baseline, 3, 6 and 12 months
9-item, subjective 7 day recall of physical activity patterns
baseline, 3, 6 and 12 months
Client Satisfaction Questionnaire
Time Frame: 3 months
intervention group only; 8 items; 4-point Likert scale; assesses general satisfaction with the health care services received; higher scores reflect higher satisfaction
3 months
6-Minute Walk Test
Time Frame: baseline, 3, 6 and 12 months
total distanced walked in 6 minutes
baseline, 3, 6 and 12 months
Accelerometry
Time Frame: baseline, 3, 6 and 12 months
accelerometers monitor/measure physical activity/sedentary behaviours for a specified period of time (7 days).
baseline, 3, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jo-Ann V Sawatzky, RN, PhD, University of Manitoba

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Anticipated)

March 1, 2018

Study Completion (Anticipated)

October 1, 2018

Study Registration Dates

First Submitted

March 30, 2015

First Submitted That Met QC Criteria

April 7, 2015

First Posted (Estimate)

April 8, 2015

Study Record Updates

Last Update Posted (Estimate)

November 2, 2016

Last Update Submitted That Met QC Criteria

October 31, 2016

Last Verified

November 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UManitoba

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on The STEP Program

3
Subscribe